Shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI), a bio-therapuetics company engaged in the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders, soared in trading on Thursday.
[...]
Recent Comments